Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
Status:
Completed
Trial end date:
2020-10-08
Target enrollment:
Participant gender:
Summary
The aim is to assess the relative efficacy of S-1 de-escalation therapy vs. continuation of
chemotherapy after induction therapy in patients with metastatic esophagogastric cancer in
terms of overall survival.